Subcellular Localization of the Huntington's Disease Gene Product in Cell Lines by Immunofluorescence and Biochemical Subcellular Fractionation

By De Rooij Karien E.   Dorsman Josephine C.   Smoor Magda A.   Den Dunnen Johan T.   Van Ommen Gert-Jan B.  

Human Molecular Genetics, Vol. 5, Iss. 8, 1996-01 ,pp. : 1093-1099

Oxford University Press

Access to resources Recommend Favorite

Huntingtin’s WW domain partners in Huntington’s disease post-mortem brain fulfill genetic criteria for direct involvement in Huntington’s disease pathogenesis

By Passani Lucius A.   Bedford MarkT.  

Human Molecular Genetics, Vol. 9, Iss. 14, 2000-09 ,pp. : 2175-2182

Oxford University Press

Access to resources Recommend Favorite

The Huntington's disease mutation impairs Huntingtin's role in the transport of NF-B from the synapse to the nucleus

By Marcora Edoardo   Kennedy Mary B.  

Human Molecular Genetics, Vol. 19, Iss. 22, 2010-11 ,pp. : 4373-4384

Oxford University Press

Access to resources Recommend Favorite

Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REG as a therapeutic target

By Bett John S.   Goellner Geoffrey M.   Woodman Ben   Pratt Gregory   Rechsteiner Martin   Bates Gillian P.  

Human Molecular Genetics, Vol. 15, Iss. 4, 2006-02 ,pp. : 665-665

Oxford University Press

Access to resources Recommend Favorite

Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REG as a therapeutic target

By Bett John S.   Goellner Geoffrey M.   Woodman Ben   Pratt Gregory   Rechsteiner Martin   Bates Gillian P.  

Human Molecular Genetics, Vol. 15, Iss. 1, 2006-01 ,pp. : 33-44

Oxford University Press

Access to resources Recommend Favorite